AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research

NIH, South African Medical Research Council award $8 million in HIV, TB grants

nih logo

The National Institutes of Health and the South African Medical Research Council (SAMRC) are awarding 31 grants to U.S. and South African scientists to support research targeting HIV/AIDS, tuberculosis and HIV-related co-morbidities and cancers. The awards, which total $8 million in first-year funding, are the first to be issued through the South Africa–U.S. Program for…

CROI 2015 Highlights: NIH’s Dr. Peter Kim Discusses Tuberculosis

croi2015_w280x100

Tuberculosis (TB) was among the several infectious diseases in addition to HIV that were important topics of discussion during the 2015 Conference on Retroviruses and Opportunistic Infections (CROI)  held in Seattle at the end of last month.  As the conference came to a close, we visited with Dr. Peter Kim about TB, his area of research at…

NIH-led study to assess community-based hepatitis C treatment in Washington, D.C.

nih logo

For Immediate Release: Friday, March 6, 2015 Officials from the National Institutes of Health and the city of Washington, D.C., launched a clinical trial to examine whether primary care physicians and other health care providers, such as nurse practitioners and physician assistants, can use a new antiviral therapy as effectively as specialist physicians to treat…

NIH Funding Opportunity for Drug Abuse Prevention Research Holds Potential for Addressing Viral Hepatitis

Ronald Valdiserri

The National Institute on Drug Abuse (NIDA), part of NIH, has released a Funding Opportunity Announcement (FOA) for research that will increase understanding of the science of drug use prevention within diverse populations and settings. Given the high prevalence of hepatitis C virus (HCV) infection among persons who inject drugs (PWID), this research also holds…

NIH-led study to assess community-based hepatitis C treatment in Washington, D.C.

nih logo

Officials from the National Institutes of Health and the city of Washington, D.C., launched a clinical trial to examine whether primary care physicians and other health care providers, such as nurse practitioners and physician assistants, can use a new antiviral therapy as effectively as specialist physicians to treat people with hepatitis C virus (HCV) infection….

Conversations from CROI 2015: Dr. Gina Brown and Dr. Ron Valdiserri on Microbicides, Women and HIV

Gina Brown and Ron Validiserri

As we approach the annual observance of National Women and Girls HIV/AIDS Awareness Day next week, we wanted to share another interview we captured at the 2015 Conference on Retroviruses and Opportunistic Infections  (CROI). While at CROI in Seattle last week, Dr. Ronald Valdiserri, Deputy Assistant Secretary for Health, Infectious Diseases, spoke with Dr. Gina…

In case you missed it: Two Video Interviews from CROI 2015

croi2015_w280x100

Editor’s Note: Earlier this week at the Conference on Retroviruses and Opportunistic Infections (CROI 2015), we released 2 video interviews by ​Dr. Ron Valdiserri, Deputy Assistant Secretary for Health, Infectious Diseases. The first video was an interview with Dr. Jonathon Mermin, Director of CDC’s National Center for HIV, Viral Hepatitis, STD, and TB Prevention. The second was an…

Final CROI 2015 Highlights from NIH’s Dr. Carl Dieffenbach

Carl Dieffenbach - NIH - CROI2015

As the 2015 Conference on Retroviruses and Opportunistic Infections (CROI)  in Seattle came to a close on Thursday, February 26, we spoke again with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID) about a highlight from the day’s presentations as well as his reflections as the…